Taiwan faces a turning point in diabetes care, balancing global breakthroughs and digital health tools with local challenges in reimbursement, stigma, and access, positioning itself to lead the region in next-generation treatment.
With structural heart disease on the rise, Edwards Lifesciences urges earlier intervention, broader access, and updated policies to help Taiwan lead in advanced cardiovascular care.
AmCham Taiwan’s 2025 Cancer Summit gathered leaders from government, industry, academia, and civil society to advance innovation and policy in cancer care. Discussions centered on early detection, sustainable funding for the Cancer Drugs Fund, and aligning with global standards to meet Taiwan’s 2030 goal of reducing cancer mortality by one-third.
Roche Taiwan is advancing personalized healthcare and driving medical innovation through strong public-private partnerships, sustainable practices, and a deep commitment to patient well-being. With pioneering work in diagnostics, oncology, and ophthalmology, the company continues to shape a healthier future for Taiwan.
Johnson & Johnson Taiwan is advancing healthcare through groundbreaking innovations in medicine and MedTech, while championing faster access, patient-centered care, and workforce development. From oncology and neuroscience to AI-powered surgery, the company is redefining what’s possible in Taiwan’s evolving healthcare landscape.
Merck Taiwan is deepening its role as a strategic innovation partner across semiconductors, biotech, and healthcare, backed by its largest-ever electronics investment and a bold push in AI, sustainability, and talent development.
Taiwan is emerging as a smart building leader in Asia, combining cybersecurity, IoT innovation, and early certification systems to drive intelligent, human-centric infrastructure. Its pioneering role is helping shape both regional policies and global standards.
Taiwan is advancing AI sovereignty by developing large language models that preserve local languages, cultural identity, and democratic values—positioning itself as a counterweight to China’s DeepSeek-R1 and other authoritarian-influenced AI systems.
Facing the urgent challenges of an aging population and rising dialysis needs, Vantive is leading the charge in transforming kidney care in Taiwan through innovative home-based treatments and digital health solutions. By promoting peritoneal dialysis and investing in remote monitoring technology, the company aims to empower patients while easing the burden on the healthcare system.
Taiwan has unveiled an ambitious new solution to tackle droughts and secure a sustainable water future, starting with a bold new structure in the hills above Taipei.
